ArticlePharmaceuticals (Basel, Switzerland)2013

Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.

Laura M Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.